Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      Bayer disagrees with German Government decision to ban Glyphosate from end of 2023

      Bayer disagrees with German Government decision to ban Glyphosate from end of 2023

      Medical Dialogues Bureau6 Sept 2019 9:00 AM IST
      "Such a ban would ignore the overwhelming scientific assessments of competent authorities around the world that have determined for more than 40 years...
      Dr Reddys unveils generic version of Zyban ER tablets in US

      Dr Reddys unveils generic version of Zyban ER tablets in US

      Medical Dialogues Bureau5 Sept 2019 5:01 PM IST
      The company has launched Bupropion hydrochloride extended-release tablets USP (SR), approved by the United States Food and Drug Administration...
      Glenmark Pharma to restructure itself into 3 entities in 2019: Chairman Glenn Saldanha

      Glenmark Pharma to restructure itself into 3 entities in 2019: Chairman Glenn Saldanha

      Medical Dialogues Bureau5 Sept 2019 9:45 AM IST
      In his message to the company's shareholders, Glenmark Pharma Chairman and MD Glenn Saldanha said the three entities will focus on different verticals...
      AstraZeneca gets Chinese marketing nod for Tagrisso to treat lung cancer

      AstraZeneca gets Chinese marketing nod for Tagrisso to treat lung cancer

      Medical Dialogues Bureau5 Sept 2019 9:30 AM IST
      China approved Tagrisso as a first-line treatment for adults with non-small cell lung cancer patients whose tumours have certain genetic mutations,...
      Novartis sees gene, cell therapy reaching up to 15pc of total revenue in midterm

      Novartis sees gene, cell therapy reaching up to 15pc of total revenue in midterm

      Medical Dialogues Bureau5 Sept 2019 9:15 AM IST
      ZURICH: Novartis sees cell and gene therapies accounting for up to 15% of its total revenue in the midterm from a much lower level at present, a Swiss...
      Lindsay Goldberg to buy Bilcare Research in a deal worth USD 279-334 million: Report

      Lindsay Goldberg to buy Bilcare Research in a deal worth USD 279-334 million: Report

      Medical Dialogues Bureau5 Sept 2019 9:00 AM IST
      Bilcare Research, which employs 1000 staff and has annual sales of 300 million euros, produces plastic packaging used in the pharmaceutical, consumer...
      Sun Pharma Revital H Woman ads misleading, inadequately substantiated: ASCI

      Sun Pharma Revital H Woman ads misleading, inadequately substantiated: ASCI

      Medical Dialogues Bureau4 Sept 2019 5:18 PM IST
      New Delhi: Country's largest drugmaker, Sun Pharmaceuticals Ltd, (Sun Pharma) has been pulled up by the Advertising Standards Council of India (ASCI)...
      Sandoz to commercialize biosimilar of MS drug Natalizumab

      Sandoz to commercialize biosimilar of MS drug Natalizumab

      Medical Dialogues Bureau4 Sept 2019 9:45 AM IST
      Under the agreement, Sandoz will commercialize and distribute natalizumab biosimilar in all markets upon approval, through an exclusive global...
      Former JnJ executive Marianne De Backer to lead Bayer pharma division

      Former JnJ executive Marianne De Backer to lead Bayer pharma division

      Medical Dialogues Bureau4 Sept 2019 9:30 AM IST
      Marianne De Backer will take the role of Head of Business Development & Licensing at Bayer's pharmaceuticals division, joining from rival JnJ,...
      Vertex Pharma, Semma enter deal worth USD 950 million to develop treatments for diabetes

      Vertex Pharma, Semma enter deal worth USD 950 million to develop treatments for diabetes

      Medical Dialogues Bureau4 Sept 2019 9:15 AM IST
      The deal represents Vertex Pharma's foray into a new treatment space, as the company typically develops treatments for cystic fibrosis, an inherited...
      Purdue Pharma prepares free-fall bankruptcy as settlement talks halt: Report

      Purdue Pharma prepares free-fall bankruptcy as settlement talks halt: Report

      Medical Dialogues Bureau4 Sept 2019 9:00 AM IST
      U.S: OxyContin maker Purdue Pharma LP is preparing to seek bankruptcy protection before the end of the month if it does not reach a settlement with...
      Zydus Cadila wins DCGI nod for marketing rabies drug Twinrab

      Zydus Cadila wins DCGI nod for marketing rabies drug Twinrab

      Medical Dialogues Bureau3 Sept 2019 10:00 AM IST
      "The novel biologic which will be marketed under the brand name, Twinrab, is indicated in combination with rabies vaccine for rabies post-exposure...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok